Dr. Jaime G Deville, M.D.
Claim this profileDavid Geffen School of Medicine at UCLA (CRS 5112)
Studies Human Immunodeficiency Virus Infection
Studies Coronavirus
7 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Jaime G Deville, M.D. is currently running
Tecovirimat
for Monkeypox
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
Recruiting1 award Phase 3
Vabomere
for Pediatric Bacterial Infections
A single dose infusion of Vabomere (meropenem-vaborbactam) is being tested for dose-finding, pharmacokinetics, safety, and tolerability in pediatric subjects from birth to less than 18 years of age with serious bacterial infections
Recruiting3 awards Phase 1
More about Jaime G Deville, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jaime G Deville, M.D. has experience with
- Dolutegravir
- ABC/DTG/3TC Film-coated Dispersible Tablets
- ABC/DTG/3TC Immediate Release Tablets
- Dolutegravir Film-coated Tablets
- Dolutegravir Film-coated Dispersible Tablets
- Anti-SARS-CoV-2 Human Convalescent Plasma
Breakdown of trials Jaime G Deville, M.D. has run
Human Immunodeficiency Virus Infection
Coronavirus
HIV/AIDS
Monkeypox
Multiplex Polymerase Chain Reaction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jaime G Deville, M.D. specialize in?
Jaime G Deville, M.D. focuses on Human Immunodeficiency Virus Infection and Coronavirus. In particular, much of their work with Human Immunodeficiency Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Jaime G Deville, M.D. currently recruiting for clinical trials?
Yes, Jaime G Deville, M.D. is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jaime G Deville, M.D. has studied deeply?
Yes, Jaime G Deville, M.D. has studied treatments such as Dolutegravir, ABC/DTG/3TC film-coated dispersible tablets, ABC/DTG/3TC immediate release tablets.
What is the best way to schedule an appointment with Jaime G Deville, M.D.?
Apply for one of the trials that Jaime G Deville, M.D. is conducting.
What is the office address of Jaime G Deville, M.D.?
The office of Jaime G Deville, M.D. is located at: David Geffen School of Medicine at UCLA (CRS 5112), Los Angeles, California 90095 United States. This is the address for their practice at the David Geffen School of Medicine at UCLA (CRS 5112).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.